Parallax Volatility Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.05M | Sell |
85,100
-43,300
| -34% | -$2.52M | 0.01% | 573 |
|
|
2025
Q4 | $6.93M | Buy |
128,400
+46,800
| +57% | +$2.25M | 0.01% | 579 |
|
|
2025
Q3 | $3.68M | Sell |
81,600
-60,800
| -43% | -$2.84M | 0.01% | 760 |
|
|
2025
Q2 | $6.59M | Buy |
142,400
+127,400
| +849% | +$6.25M | 0.01% | 552 |
|
|
2025
Q1 | $915K | Sell |
15,000
-438,500
| -97% | -$25.6M | ﹤0.01% | 1078 |
|
|
2024
Q4 | $25.6M | Buy |
453,500
+360,200
| +386% | +$20.1M | 0.05% | 303 |
|
|
2024
Q3 | $4.83M | Buy |
93,300
+49,800
| +114% | +$2.34M | 0.01% | 804 |
|
|
2024
Q2 | $1.81M | Sell |
43,500
-173,000
| -80% | -$7.74M | ﹤0.01% | 1075 |
|
|
2024
Q1 | $11.7M | Sell |
216,500
-168,500
| -44% | -$8.58M | 0.03% | 471 |
|
|
2023
Q4 | $19.8M | Buy |
385,000
+245,700
| +176% | +$12.9M | 0.04% | 393 |
|
|
2023
Q3 | $8.08M | Sell |
139,300
-6,700
| -5% | -$411K | 0.02% | 595 |
|
|
2023
Q2 | $9.34M | Sell |
146,000
-468,000
| -76% | -$31.4M | 0.02% | 560 |
|
|
2023
Q1 | $42.6M | Buy |
614,000
+67,200
| +12% | +$4.74M | 0.09% | 225 |
|
|
2022
Q4 | $39.3M | Buy |
546,800
+110,600
| +25% | +$8.34M | 0.06% | 333 |
|
|
2022
Q3 | $31M | Sell |
436,200
-80,400
| -16% | -$5.83M | 0.05% | 403 |
|
|
2022
Q2 | $39.8M | Buy |
516,600
+418,100
| +424% | +$31.8M | 0.04% | 330 |
|
|
2022
Q1 | $7.19M | Buy |
+98,500
| New | +$6.61M | ﹤0.01% | 857 |
|
|
2020
Q4 | – | Sell |
-1,351,300
| Closed | -$81.5M | – | 2478 |
|
|
2020
Q3 | $81.5M | Buy |
1,351,300
+858,300
| +174% | +$51.7M | 0.06% | 279 |
|
|
2020
Q2 | $29M | Sell |
493,000
-3,415,800
| -87% | -$204M | 0.03% | 403 |
|
|
2020
Q1 | $218M | Buy |
3,908,800
+3,314,100
| +557% | +$203M | 0.28% | 51 |
|
|
2019
Q4 | $38.2M | Buy |
594,700
+434,000
| +270% | +$24.9M | 0.04% | 258 |
|
|
2019
Q3 | $8.15M | Sell |
160,700
-210,000
| -57% | -$9.87M | 0.01% | 657 |
|
|
2019
Q2 | $16.8M | Sell |
370,700
-317,700
| -46% | -$14.8M | 0.02% | 403 |
|
|
2019
Q1 | $32.8M | Sell |
688,400
-90,300
| -12% | -$4.5M | 0.04% | 226 |
|
|
2018
Q4 | $40.5M | Sell |
778,700
-99,700
| -11% | -$5.36M | 0.05% | 220 |
|
|
2018
Q3 | $54.5M | Sell |
878,400
-161,600
| -16% | -$9.59M | 0.07% | 125 |
|
|
2018
Q2 | $57.6M | Buy |
1,040,000
+945,000
| +995% | +$51M | 0.08% | 105 |
|
|
2018
Q1 | $6.01M | Sell |
95,000
-45,000
| -32% | -$2.89M | 0.01% | 471 |
|
|
2017
Q4 | $8.58M | Buy |
+140,000
| New | +$8.76M | 0.01% | 455 |
|
|
2017
Q1 | – | Sell |
-27,000
| Closed | -$1.58M | – | 3570 |
|
|
2016
Q4 | $1.58M | Hold |
27,000
| – | – | ﹤0.01% | 1060 |
|
|
2016
Q3 | $1.46M | Sell |
27,000
-1,600
| -6% | -$103K | ﹤0.01% | 1110 |
|
|
2016
Q2 | $2.1M | Sell |
28,600
-11,200
| -28% | -$791K | ﹤0.01% | 911 |
|
|
2016
Q1 | $2.54M | Sell |
39,800
-64,600
| -62% | -$4.07M | 0.01% | 823 |
|
|
2015
Q4 | $7.18M | Sell |
104,400
-63,300
| -38% | -$4.18M | 0.01% | 554 |
|
|
2015
Q3 | $9.93M | Buy |
167,700
+88,000
| +110% | +$5.58M | 0.02% | 452 |
|
|
2015
Q2 | $5.3M | Sell |
79,700
-130,500
| -62% | -$8.6M | 0.01% | 695 |
|
|
2015
Q1 | $13.6M | Sell |
210,200
-207,700
| -50% | -$13M | 0.03% | 389 |
|
|
2014
Q4 | $24.7M | Buy |
417,900
+15,000
| +4% | +$846K | 0.07% | 258 |
|
|
2014
Q3 | $20.6M | Buy |
402,900
+120,200
| +43% | +$6M | 0.07% | 254 |
|
|
2014
Q2 | $13.7M | Buy |
282,700
+35,600
| +14% | +$1.75M | 0.06% | 250 |
|
|
2014
Q1 | $12.8M | Sell |
247,100
-498,700
| -67% | -$26.5M | 0.08% | 209 |
|
|
2013
Q4 | $39.6M | Buy |
745,800
+297,000
| +66% | +$15.1M | 0.19% | 111 |
|
|
2013
Q3 | $20.8M | Sell |
448,800
-11,300
| -2% | -$496K | 0.11% | 164 |
|
|
2013
Q2 | $20.6M | Buy |
+460,100
| New | +$20M | 0.1% | 164 |
|
Other funds holding BMY
VCM
VPM
Parallax Volatility Advisers's BMY Position: Q1 2026 in Review
Parallax Volatility Advisers opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 30,431 shares worth $1.81M. The stake represents ﹤0.01% of the portfolio and ranks #813 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in BMY as recently as Q2 2025.
Parallax Volatility Advisers first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $95M in Q1 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Parallax Volatility Advisers held 30,431 shares of Bristol-Myers Squibb worth $1.81M as of Q1 2026.
- Bristol-Myers Squibb was a new Parallax Volatility Advisers position in Q1 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #813 holding.
- Parallax Volatility Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
- Parallax Volatility Advisers's Bristol-Myers Squibb position peaked at $95M in Q1 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.